Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
DIAGNOS INC (ADK.CA) Stock Price & Overview
TSX-V:ADK • CA2524423068
Current stock price
0.24 CAD
0 (0%)
Last:
The current stock price of ADK.CA is 0.24 CAD. Today ADK.CA is down by 0%. In the past month the price decreased by -12.96%. In the past year, price decreased by -6%.
ADK.CA Key Statistics
52-Week Range0.18 - 0.415
Current ADK.CA stock price positioned within its 52-week range.
1-Month Range0.23 - 0.29
Current ADK.CA stock price positioned within its 1-month range.
- Market Cap
- 28.898M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.04
- Dividend Yield
- N/A
ADK.CA Stock Performance
Today
0%
1 Week
-6.00%
1 Month
-12.96%
3 Months
-20.34%
Longer-term
6 Months -30.88%
1 Year -6.00%
2 Years -14.55%
3 Years -35.62%
5 Years -60.17%
10 Years -60.83%
ADK.CA Stock Chart
ADK.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ADK.CA. When comparing the yearly performance of all stocks, ADK.CA is a bad performer in the overall market: 86.33% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
ADK.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ADK.CA. ADK.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ADK.CA Earnings
Next Earnings DateMay 26, 2026
Last Earnings DateFeb 25, 2026
PeriodQ3 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
ADK.CA Forecast & Estimates
Analysts
Analysts84.44
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
ADK.CA Financial Highlights
Over the last trailing twelve months ADK.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 0.66% compared to the year before.
Income Statements
Revenue(TTM)68.20K
Net Income(TTM)-4.71M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -120.6% | ||
| ROE | -314.72% | ||
| Debt/Equity | 0.2 |
Chartmill High Growth Momentum
EPS Q2Q%23.26%
Sales Q2Q%-41.54%
EPS 1Y (TTM)0.66%
Revenue 1Y (TTM)-46.47%
ADK.CA Ownership
Ownership
Inst Owners0.28%
Shares120.41M
Float107.12M
Ins Owners4.08%
Short Float %N/A
Short RatioN/A
ADK.CA Industry Overview
ADK.CA operates in the Health Care Technology sub-industry within the Health Care sector. This group contains 8 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
46/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
65%
Outperformed 65% of sub-industries
3 Month Rank
4%
Outperformed 4% of sub-industries
6 Month Rank
9%
Outperformed 9% of sub-industries
Industry Fundamentals & Breadth
- Members
- 8
- New Highs
- 0%
- New Lows
- 25%
- Average ROE
- 3%
- Average Profit Margin
- 4.5%
- Average Operating Margin
- 8.1%
- Average P/E
- 191.2
- Average Fwd P/E
- 27.0
- Average Debt/Equity
- 0.2
ADK.CA Competitors/Peers
The largest stocks on the Canadian markets in the "Health Care Technology" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VHI | VITALHUB CORP | 31.72 | 524.975M | ||
| NURS | HYDREIGHT TECHNOLOGIES INC | 13.2 | 215.736M | ||
| AIAI | NETRAMARK HOLDINGS INC | N/A | 87.091M | ||
| KDA | KDA GROUP INC | N/A | 27.031M | ||
| AVCR | AVRICORE HEALTH INC | N/A | 6.077M | ||
| KOVO | KOVO+ HOLDINGS INC | N/A | 2.653M | ||
| EKG | CARDIOCOMM SOLUTIONS INC | N/A | 1.976M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About ADK.CA
Company Profile
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Company Info
IPO: 2000-09-27
DIAGNOS INC
7005 Taschereau Blvd Suite 340
Brossard QUEBEC J4Z 1A7 CA
CEO: Andre Larente
Employees: 16
Phone: 14506788882
DIAGNOS INC / ADK.CA FAQ
Can you describe the business of DIAGNOS INC?
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
What is the stock price of DIAGNOS INC today?
The current stock price of ADK.CA is 0.24 CAD.
Does DIAGNOS INC pay dividends?
ADK.CA does not pay a dividend.
How is the ChartMill rating for DIAGNOS INC?
ADK.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How many employees does DIAGNOS INC have?
DIAGNOS INC (ADK.CA) currently has 16 employees.
When does DIAGNOS INC (ADK.CA) report earnings?
DIAGNOS INC (ADK.CA) will report earnings on 2026-05-26.